Vaporization of a symptomatic floater is an alluring idea that first became a reality several years ago. In 1993, Tsai and colleagues1 reported a series of 15 patients who underwent Nd:YAG laser vaporization of floaters. With use of laser energies of 5 to 10 mJ per burst, Weiss rings or central vitreous opacities were disrupted, and no complications were reported at 12 months. Since then, others2-6 have reported variable success rates and complications, which have tempered the widespread adoption of the treatment. In this issue of JAMA Ophthalmology, Shah and Heier7 report their experience in treatment of symptomatic Weiss rings.